Korro Bio
KRRO
84 hedge funds and large institutions have $360M invested in Korro Bio in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 33 increasing their positions, 14 reducing their positions, and 9 closing their positions.
167% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 9
136% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 14
26% more capital invested
Capital invested by funds: $285M → $360M (+$74.3M)
18% more funds holding
Funds holding: 71 → 84 (+13)
9.03% more ownership
Funds ownership: 91.8% → 100.82% (+9%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$36.3M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$17.5M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
+$5.25M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$4.72M |
| 5 |
TLP
Tri Locum Partners
New York
|
+$4.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$14.1M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$8.88M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$8.19M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.43M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$1.6M |
KRRO Hedge Fund Activity: Q4 2024 in Review
84 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q4 2024, worth a combined $360M — up 26% from $285M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new KRRO positions and 9 closed out — a net gain of 15 holders — while 33 added to existing stakes and 14 trimmed.
The largest buyer was AllianceBernstein, opening a new position worth an estimated $36.3M. The largest seller was Eventide Asset Management, cutting an estimated $14.1M.
- 84 institutional investors held Korro Bio (KRRO) as of Q4 2024, up from 71 in Q3 2024.
- Funds reported $360M of Korro Bio stock for Q4 2024, up 26% quarter-over-quarter.
- 24 funds opened new Korro Bio positions in Q4 2024 and 9 closed out, a net change of +15 holders.
- The largest Korro Bio buyer in Q4 2024 was AllianceBernstein, an estimated $36.3M added.
- The largest Korro Bio seller in Q4 2024 was Eventide Asset Management, an estimated $14.1M sold.
Based on aggregated 13F filings for Q4 2024.